Tech & Innovation

Is Virtual Care Revolutionizing Healthcare Delivery and Outcomes?
Tech & Innovation Is Virtual Care Revolutionizing Healthcare Delivery and Outcomes?

Ivan Kairatov is a Biopharma expert with extensive knowledge of tech and innovation in the healthcare industry and significant experience in research and development. Today we will discuss the recent 2025 Digital Health Survey by Black Book Research, which covers various aspects of virtual care

Ecopipam Nears FDA Approval for Tourette Syndrome Treatment
Tech & Innovation Ecopipam Nears FDA Approval for Tourette Syndrome Treatment

Tourette syndrome is a complex condition marked by involuntary motor and vocal tics, significantly impacting the lives of those affected. For years, the medical community has struggled to find an effective treatment that targets the root cause of these symptoms. This struggle has led to the

Netsmart Showcases AI Innovations at mhca 2025 Winter Conference
Tech & Innovation Netsmart Showcases AI Innovations at mhca 2025 Winter Conference

Introducing Ivan Kairatov, a biopharma expert with extensive knowledge in tech and innovation within the industry, and experience in research and development. Today, Ivan will share insights into Netsmart's upcoming showcases and developments in AI and healthcare technology as they prepare for

How Can Adaptive DBS Transform Parkinson's Disease Treatment?
Tech & Innovation How Can Adaptive DBS Transform Parkinson's Disease Treatment?

Ivan Kairatov is a Biopharma expert with deep knowledge of technology and innovation in the industry, with experience in research and development. Today, we discuss the recent FDA approval of adaptive deep brain stimulation (aDBS) as a new treatment option for Parkinson’s disease. Can you explain w

How Is AI Transforming Diagnosis and Prognosis of OPMDs?
Tech & Innovation How Is AI Transforming Diagnosis and Prognosis of OPMDs?

The transformative role of artificial intelligence (AI) and deep learning (DL) in the realm of medical imaging is ushering in a new era for the diagnosis and prognosis of oral potentially malignant disorders (OPMDs). These technologies are spearheading advancements in early detection and risk

Insilico and Therasid Collaborate to Advance AI-Driven MASH Treatments
Tech & Innovation Insilico and Therasid Collaborate to Advance AI-Driven MASH Treatments

In the rapidly evolving landscape of biotechnology, the merger of artificial intelligence and drug discovery continues to unlock groundbreaking advances in medical treatments. The latest collaboration between Insilico Medicine and Therasid Bioscience highlights the transformative potential of

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later